<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32712030</PMID><DateCompleted><Year>2021</Year><Month>03</Month><Day>05</Day></DateCompleted><DateRevised><Year>2021</Year><Month>11</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1090-2430</ISSN><JournalIssue CitedMedium="Internet"><Volume>333</Volume><PubDate><Year>2020</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Experimental neurology</Title><ISOAbbreviation>Exp Neurol</ISOAbbreviation></Journal><ArticleTitle>Elevated exosomal secretion of miR-124-3p from spinal neurons positively associates with disease severity in ALS.</ArticleTitle><Pagination><StartPage>113414</StartPage><MedlinePgn>113414</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.expneurol.2020.113414</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0014-4886(20)30245-4</ELocationID><Abstract><AbstractText>MicroRNAs (miRs) are powerful regulators of CNS development and diseases. Plasma and cerebrospinal fluid (CSF) miRs have recently been implicated as potential new sources for biomarker development. Previously we showed that miR-124-3p, an essential miR for neuronal identity, is highly abundant in neuronal exosomes and its expression decreases in spinal cord of ALS model SOD1G93A mice. In the current study, we found a disease associated reduction of miR-124-3p levels specifically in spinal neurons using in situ hybridization. By employing our recently developed exosome reporter mice in combination with sciatic nerve injections, we observed an increased association of miR-124-3p with spinal motor neuron-derived exosomes in SOD1G93A mice, even at the pre-symptomatic stage. Sciatic nerve injection delivered miR-124-3p is also more frequently localized outside of spinal motor neurons in SOD1G93A mice. Subsequent quantitative analysis of miR-124-3p levels in CSF exosomes from ALS patients found a significant correlation between CSF exosomal miR-124-3p levels and disease stage (indicated by the ALSFRS-R score) of (male) ALS patients. These results provide preliminary evidence to support the potential use of CSF exosomal miR-124-3p as a disease stage indicator in ALS.</AbstractText><CopyrightInformation>Copyright &#xa9; 2020 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yelick</LastName><ForeName>Julia</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Tufts University School of Medicine, Department of Neuroscience, 136 Harrison Ave, Boston, MA 02111, United States of America; Tufts University, Graudate School of Biomedical Sciences, 145 Harrison Ave, Boston, MA 02111, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Men</LastName><ForeName>Yuqin</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Tufts University School of Medicine, Department of Neuroscience, 136 Harrison Ave, Boston, MA 02111, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jin</LastName><ForeName>Shijie</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Tufts University School of Medicine, Department of Neuroscience, 136 Harrison Ave, Boston, MA 02111, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Seo</LastName><ForeName>Sabrina</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Tufts University School of Medicine, Department of Neuroscience, 136 Harrison Ave, Boston, MA 02111, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Espejo-Porras</LastName><ForeName>Francisco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Tufts University School of Medicine, Department of Neuroscience, 136 Harrison Ave, Boston, MA 02111, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Yongjie</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Tufts University School of Medicine, Department of Neuroscience, 136 Harrison Ave, Boston, MA 02111, United States of America; Tufts University, Graudate School of Biomedical Sciences, 145 Harrison Ave, Boston, MA 02111, United States of America. Electronic address: yongjie.yang@tufts.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R21 DA042342</GrantID><Acronym>DA</Acronym><Agency>NIDA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R21 NS087391</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>RF1 AG057882</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>RF1 AG059610</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>07</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Exp Neurol</MedlineTA><NlmUniqueID>0370712</NlmUniqueID><ISSNLinking>0014-4886</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C509207">MIRN124 microRNA, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D035683">MicroRNAs</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="C000606291">Sod1 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055354" MajorTopicYN="N">Exosomes</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055879" MajorTopicYN="N">Gene Knock-In Techniques</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007267" MajorTopicYN="N">Injections</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D035683" MajorTopicYN="N">MicroRNAs</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000134" MajorTopicYN="N">cerebrospinal fluid</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009474" MajorTopicYN="N">Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012584" MajorTopicYN="N">Sciatic Nerve</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013116" MajorTopicYN="N">Spinal Cord</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="N">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000134" MajorTopicYN="N">cerebrospinal fluid</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>Declaration of Competing Interest The authors declare no conflict of interest in this study.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>3</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>6</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>7</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>7</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>3</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>7</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32712030</ArticleId><ArticleId IdType="mid">NIHMS1616085</ArticleId><ArticleId IdType="pmc">PMC7502520</ArticleId><ArticleId IdType="doi">10.1016/j.expneurol.2020.113414</ArticleId><ArticleId IdType="pii">S0014-4886(20)30245-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Taylor JP, Brown RH Jr. and Cleveland DW (2016) Decoding ALS: from genes to mechanism. Nature, 539, 197&#x2013;206.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5585017</ArticleId><ArticleId IdType="pubmed">27830784</ArticleId></ArticleIdList></Reference><Reference><Citation>Cleveland DW and Rothstein JD (2001) From Charcot to Lou Gehrig: deciphering selective motor neuron death in ALS. Nat Rev Neurosci, 2, 806&#x2013;819.</Citation><ArticleIdList><ArticleId IdType="pubmed">11715057</ArticleId></ArticleIdList></Reference><Reference><Citation>Ilieva H, Polymenidou M and Cleveland DW (2009) Non-cell autonomous toxicity in neurodegenerative disorders: ALS and beyond. J Cell Biol, 187, 761&#x2013;772.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2806318</ArticleId><ArticleId IdType="pubmed">19951898</ArticleId></ArticleIdList></Reference><Reference><Citation>Rothstein JD, Martin LJ and Kuncl RW (1992) Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis. N Engl.J Med, 326, 1464&#x2013;1468.</Citation><ArticleIdList><ArticleId IdType="pubmed">1349424</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee Y, Morrison BM, Li Y, Lengacher S, Farah MH, Hoffman PN, Liu Y, Tsingalia A, Jin L, Zhang PW et al. (2012) Oligodendroglia metabolically support axons and contribute to neurodegeneration. Nature, 487, 443&#x2013;448.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3408792</ArticleId><ArticleId IdType="pubmed">22801498</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang SH, Fukaya M, Yang JK, Rothstein JD and Bergles DE (2010) NG2+ CNS glial progenitors remain committed to the oligodendrocyte lineage in postnatal life and following neurodegeneration. Neuron, 68, 668&#x2013;681.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2989827</ArticleId><ArticleId IdType="pubmed">21092857</ArticleId></ArticleIdList></Reference><Reference><Citation>Conaco C, Otto S, Han JJ and Mandel G (2006) Reciprocal actions of REST and a microRNA promote neuronal identity. Proc Natl Acad Sci U S A, 103, 2422&#x2013;2427.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1413753</ArticleId><ArticleId IdType="pubmed">16461918</ArticleId></ArticleIdList></Reference><Reference><Citation>Packer AN, Xing Y, Harper SQ, Jones L and Davidson BL (2008) The bifunctional microRNA miR-9/miR-9* regulates REST and CoREST and is downregulated in Huntington&#x2019;s disease. J Neurosci, 28, 14341&#x2013;14346.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3124002</ArticleId><ArticleId IdType="pubmed">19118166</ArticleId></ArticleIdList></Reference><Reference><Citation>McNeill E and Van Vactor D (2012) MicroRNAs shape the neuronal landscape. Neuron, 75, 363&#x2013;379.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3441179</ArticleId><ArticleId IdType="pubmed">22884321</ArticleId></ArticleIdList></Reference><Reference><Citation>Amin ND, Bai G, Klug JR, Bonanomi D, Pankratz MT, Gifford WD, Hinckley CA, Sternfeld MJ, Driscoll SP, Dominguez B et al. (2015) Loss of motoneuron-specific microRNA-218 causes systemic neuromuscular failure. Science, 350, 1525&#x2013;1529.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4913787</ArticleId><ArticleId IdType="pubmed">26680198</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawahara Y and Mieda-Sato A (2012) TDP-43 promotes microRNA biogenesis as a component of the Drosha and Dicer complexes. Proc Natl Acad Sci U S A, 109, 3347&#x2013;3352.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3295278</ArticleId><ArticleId IdType="pubmed">22323604</ArticleId></ArticleIdList></Reference><Reference><Citation>Morlando M, Dini Modigliani S, Torrelli G, Rosa A, Di Carlo V, Caffarelli E and Bozzoni I (2012) FUS stimulates microRNA biogenesis by facilitating co-transcriptional Drosha recruitment. EMBO J, 31, 4502&#x2013;4510.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3545295</ArticleId><ArticleId IdType="pubmed">23232809</ArticleId></ArticleIdList></Reference><Reference><Citation>De Santis R, Santini L, Colantoni A, Peruzzi G, de Turris V, Alfano V, Bozzoni I and Rosa A (2017) FUS Mutant Human Motoneurons Display Altered Transcriptome and microRNA Pathways with Implications for ALS Pathogenesis. Stem Cell Reports, 9, 1450&#x2013;1462.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5830977</ArticleId><ArticleId IdType="pubmed">28988989</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoye ML, Koval ED, Wegener AJ, Hyman TS, Yang C, O&#x2019;Brien DR, Miller RL, Cole T, Schoch KM, Shen T et al. (2017) MicroRNA Profiling Reveals Marker of Motor Neuron Disease in ALS Models. J Neurosci, 37, 5574&#x2013;5586.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5452343</ArticleId><ArticleId IdType="pubmed">28416596</ArticleId></ArticleIdList></Reference><Reference><Citation>Koval ED, Shaner C, Zhang P, du Maine X, Fischer K, Tay J, Chau BN, Wu GF and Miller TM (2013) Method for widespread microRNA-155 inhibition prolongs survival in ALS-model mice. Hum Mol Genet, 22, 4127&#x2013;4135.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3781640</ArticleId><ArticleId IdType="pubmed">23740943</ArticleId></ArticleIdList></Reference><Reference><Citation>Butovsky O, Jedrychowski MP, Cialic R, Krasemann S, Murugaiyan G, Fanek Z, Greco DJ, Wu PM, Doykan CE, Kiner O et al. (2015) Targeting miR-155 restores abnormal microglia and attenuates disease in SOD1 mice. Ann Neurol, 77, 75&#x2013;99.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4432483</ArticleId><ArticleId IdType="pubmed">25381879</ArticleId></ArticleIdList></Reference><Reference><Citation>Parisi C, Napoli G, Amadio S, Spalloni A, Apolloni S, Longone P and Volonte C (2016) MicroRNA-125b regulates microglia activation and motor neuron death in ALS. Cell Death Differ, 23, 531&#x2013;541.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5072447</ArticleId><ArticleId IdType="pubmed">26794445</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams AH, Valdez G, Moresi V, Qi X, McAnally J, Elliott JL, Bassel-Duby R, Sanes JR and Olson EN (2009) MicroRNA-206 delays ALS progression and promotes regeneration of neuromuscular synapses in mice. Science, 326, 1549&#x2013;1554.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2796560</ArticleId><ArticleId IdType="pubmed">20007902</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J, Li S, Li L, Li M, Guo C, Yao J and Mi S (2015) Exosome and exosomal microRNA: trafficking, sorting, and function. Genomics Proteomics Bioinformatics, 13, 17&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4411500</ArticleId><ArticleId IdType="pubmed">25724326</ArticleId></ArticleIdList></Reference><Reference><Citation>Colombo M, Raposo G and Thery C (2014) Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles. Annu Rev Cell Dev Biol, 30, 255&#x2013;289.</Citation><ArticleIdList><ArticleId IdType="pubmed">25288114</ArticleId></ArticleIdList></Reference><Reference><Citation>Morel L, Regan M, Higashimori H, Ng SK, Esau C, Vidensky S, Rothstein J and Yang Y (2013) Neuronal exosomal miRNA-dependent translational regulation of astroglial glutamate transporter GLT1. J Biol Chem, 288, 7105&#x2013;7116.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3591620</ArticleId><ArticleId IdType="pubmed">23364798</ArticleId></ArticleIdList></Reference><Reference><Citation>Rinchetti P, Rizzuti M, Faravelli I and Corti S (2018) MicroRNA Metabolism and Dysregulation in Amyotrophic Lateral Sclerosis. Mol Neurobiol, 55, 2617&#x2013;2630.</Citation><ArticleIdList><ArticleId IdType="pubmed">28421535</ArticleId></ArticleIdList></Reference><Reference><Citation>Waller R, Wyles M, Heath PR, Kazoka M, Wollff H, Shaw PJ and Kirby J (2017) Small RNA Sequencing of Sporadic Amyotrophic Lateral Sclerosis Cerebrospinal Fluid Reveals Differentially Expressed miRNAs Related to Neural and Glial Activity. Front Neurosci, 11, 731.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5767269</ArticleId><ArticleId IdType="pubmed">29375285</ArticleId></ArticleIdList></Reference><Reference><Citation>Men Y, Yelick J, Jin S, Tian Y, Chiang MSR, Higashimori H, Brown E, Jarvis R and Yang Y (2019) Exosome reporter mice reveal the involvement of exosomes in mediating neuron to astroglia communication in the CNS. Nat Commun, 10, 4136.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6742670</ArticleId><ArticleId IdType="pubmed">31515491</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhinge A, Namboori SC, Bithell A, Soldati C, Buckley NJ and Stanton LW (2016) MiR-375 is Essential for Human Spinal Motor Neuron Development and May Be Involved in Motor Neuron Degeneration. Stem Cells, 34, 124&#x2013;134.</Citation><ArticleIdList><ArticleId IdType="pubmed">26507573</ArticleId></ArticleIdList></Reference><Reference><Citation>Ponomarev ED, Veremeyko T, Barteneva N, Krichevsky AM and Weiner HL (2011) MicroRNA-124 promotes microglia quiescence and suppresses EAE by deactivating macrophages via the C/EBP-alpha-PU.1 pathway. Nat Med, 17, 64&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3044940</ArticleId><ArticleId IdType="pubmed">21131957</ArticleId></ArticleIdList></Reference><Reference><Citation>He L and Hannon GJ (2004) MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet, 5, 522&#x2013;531.</Citation><ArticleIdList><ArticleId IdType="pubmed">15211354</ArticleId></ArticleIdList></Reference><Reference><Citation>Fabbri M, Garzon R, Andreeff M, Kantarjian HM, Garcia-Manero G and Calin GA (2008) MicroRNAs and noncoding RNAs in hematological malignancies: molecular, clinical and therapeutic implications. Leukemia, 22, 1095&#x2013;1105.</Citation><ArticleIdList><ArticleId IdType="pubmed">18323801</ArticleId></ArticleIdList></Reference><Reference><Citation>Cedarbaum JM, Stambler N, Malta E, Fuller C, Hilt D, Thurmond B and Nakanishi A (1999) The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III). J Neurol Sci, 169, 13&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pubmed">10540002</ArticleId></ArticleIdList></Reference><Reference><Citation>Maas SL, Broekman ML and de Vrij J (2017) Tunable Resistive Pulse Sensing for the Characterization of Extracellular Vesicles. Methods Mol Biol, 1545, 21&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="pubmed">27943204</ArticleId></ArticleIdList></Reference><Reference><Citation>Vogel R, Willmott G, Kozak D, Roberts GS, Anderson W, Groenewegen L, Glossop B, Barnett A, Turner A and Trau M (2011) Quantitative sizing of nano/microparticles with a tunable elastomeric pore sensor. Anal Chem, 83, 3499&#x2013;3506.</Citation><ArticleIdList><ArticleId IdType="pubmed">21434639</ArticleId></ArticleIdList></Reference><Reference><Citation>Soares Martins T, Catita J, Martins Rosa I, A.B.d.C.E.S. O and Henriques AG (2018) Exosome isolation from distinct biofluids using precipitation and column-based approaches. PLoS One, 13, e0198820.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5995457</ArticleId><ArticleId IdType="pubmed">29889903</ArticleId></ArticleIdList></Reference><Reference><Citation>Rider MA, Hurwitz SN and Meckes DG Jr. (2016) ExtraPEG: A Polyethylene Glycol-Based Method for Enrichment of Extracellular Vesicles. Sci Rep, 6, 23978.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4828635</ArticleId><ArticleId IdType="pubmed">27068479</ArticleId></ArticleIdList></Reference><Reference><Citation>Bilsland LG, Sahai E, Kelly G, Golding M, Greensmith L and Schiavo G (2010) Deficits in axonal transport precede ALS symptoms in vivo. Proc Natl Acad Sci U S A, 107, 20523&#x2013;20528.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2996651</ArticleId><ArticleId IdType="pubmed">21059924</ArticleId></ArticleIdList></Reference><Reference><Citation>Williamson TL and Cleveland DW (1999) Slowing of axonal transport is a very early event in the toxicity of ALS-linked SOD1 mutants to motor neurons. Nat Neurosci, 2, 50&#x2013;56.</Citation><ArticleIdList><ArticleId IdType="pubmed">10195180</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner MR, Kiernan MC, Leigh PN and Talbot K (2009) Biomarkers in amyotrophic lateral sclerosis. The Lancet. Neurology, 8, 94&#x2013;109.</Citation><ArticleIdList><ArticleId IdType="pubmed">19081518</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X and Shang HF (2015) New developments and future opportunities in biomarkers for amyotrophic lateral sclerosis. Transl Neurodegener, 4, 17.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4589120</ArticleId><ArticleId IdType="pubmed">26425343</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanninen KM, Bister N, Koistinaho J and Malm T (2016) Exosomes as new diagnostic tools in CNS diseases. Biochim Biophys Acta, 1862, 403&#x2013;410.</Citation><ArticleIdList><ArticleId IdType="pubmed">26432482</ArticleId></ArticleIdList></Reference><Reference><Citation>Grad LI, Yerbury JJ, Turner BJ, Guest WC, Pokrishevsky E, O&#x2019;Neill MA, Yanai A, Silverman JM, Zeineddine R, Corcoran L et al. (2014) Intercellular propagated misfolding of wild-type Cu/Zn superoxide dismutase occurs via exosome-dependent and -independent mechanisms. Proc Natl Acad Sci U S A, 111, 3620&#x2013;3625.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3948312</ArticleId><ArticleId IdType="pubmed">24550511</ArticleId></ArticleIdList></Reference><Reference><Citation>Iguchi Y, Eid L, Parent M, Soucy G, Bareil C, Riku Y, Kawai K, Takagi S, Yoshida M, Katsuno M et al. (2016) Exosome secretion is a key pathway for clearance of pathological TDP-43. Brain, 139, 3187&#x2013;3201.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5840881</ArticleId><ArticleId IdType="pubmed">27679482</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamelgarn M, Chen J, Kuang L, Arenas A, Zhai J, Zhu H and Gal J (2016) Proteomic analysis of FUS interacting proteins provides insights into FUS function and its role in ALS. Biochim Biophys Acta, 1862, 2004&#x2013;2014.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5055831</ArticleId><ArticleId IdType="pubmed">27460707</ArticleId></ArticleIdList></Reference><Reference><Citation>Westergard T, Jensen BK, Wen X, Cai J, Kropf E, Iacovitti L, Pasinelli P and Trotti D (2016) Cell-to-Cell Transmission of Dipeptide Repeat Proteins Linked to C9orf72-ALS/FTD. Cell Rep, 17, 645&#x2013;652.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5078984</ArticleId><ArticleId IdType="pubmed">27732842</ArticleId></ArticleIdList></Reference><Reference><Citation>Steinacker P, Hendrich C, Sperfeld AD, Jesse S, von Arnim CA, Lehnert S, Pabst A, Uttner I, Tumani H, Lee VM et al. (2008) TDP-43 in cerebrospinal fluid of patients with frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Arch Neurol, 65, 1481&#x2013;1487.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2690860</ArticleId><ArticleId IdType="pubmed">19001167</ArticleId></ArticleIdList></Reference><Reference><Citation>Lafourcade C, Ramirez JP, Luarte A, Fernandez A and Wyneken U (2016) MiRNAs in Astrocyte-Derived Exosomes as Possible Mediators of Neuronal Plasticity. J Exp Neurosci, 10, 1&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4978198</ArticleId><ArticleId IdType="pubmed">27547038</ArticleId></ArticleIdList></Reference><Reference><Citation>Jovicic A and Gitler AD (2017) Distinct repertoires of microRNAs present in mouse astrocytes compared to astrocyte-secreted exosomes. PLoS One, 12, e0171418.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5289606</ArticleId><ArticleId IdType="pubmed">28152040</ArticleId></ArticleIdList></Reference><Reference><Citation>McCombe PA and Henderson RD (2010) Effects of gender in amyotrophic lateral sclerosis. Gend Med, 7, 557&#x2013;570.</Citation><ArticleIdList><ArticleId IdType="pubmed">21195356</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo L, Liang T, Yu J and Zou Q (2016) A Comprehensive Analysis of miRNA/isomiR Expression with Gender Difference. PLoS One, 11, e0154955.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4864079</ArticleId><ArticleId IdType="pubmed">27167065</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui C, Yang W, Shi J, Zhou Y, Yang J, Cui Q and Zhou Y (2018) Identification and Analysis of Human Sex-biased MicroRNAs. Genomics Proteomics Bioinformatics, 16, 200&#x2013;211.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6076379</ArticleId><ArticleId IdType="pubmed">30005964</ArticleId></ArticleIdList></Reference><Reference><Citation>Silahtaroglu AN (2010) LNA-FISH for detection of microRNAs in frozen sections. Methods Mol Biol, 659, 165&#x2013;171.</Citation><ArticleIdList><ArticleId IdType="pubmed">20809310</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>